Gerresheimer AG (ETR:GXI – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as €73.85 ($78.56) and last traded at €75.20 ($80.00), with a volume of 125943 shares trading hands. The stock had previously closed at €74.15 ($78.88).
Gerresheimer Stock Performance
The company has a debt-to-equity ratio of 79.36, a quick ratio of 0.40 and a current ratio of 0.87. The firm’s 50 day simple moving average is €88.02 and its 200-day simple moving average is €95.72. The company has a market cap of $2.60 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 0.82 and a beta of 0.94.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Featured Articles
- Five stocks we like better than Gerresheimer
- How to Calculate Return on Investment (ROI)
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- How to Buy Cheap Stocks Step by Step
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.